Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Solifenacin Effect on Urinary Microbiome in OAB
NCT01642277Phase 2Completed
- Sponsor
- Loyola University Chicago
- Start
- Jul 2012
- Primary completion
- Jul 2014
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 2 trial of solifenacin in overactive bladder (OAB), sponsored by Loyola University Chicago. Started Jul 2012; status: completed.
02
Drugs
solifenacin
03
Conditions
overactive bladder (OAB)
Beyond the preview
Go deeper on NCT01642277.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01642277.